ER-KANG: Vitamin B6 injection has passed the consistency evaluation of generic drugs
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, ER-KANG announced that the company recently received the "Notice of Approval for Supplementary Drug Application" (Notice No.: 2025B02458) issued by the National Medical Products Administration. The company's Vitamin B6 injection 1ml:100mg specification has passed the consistency evaluation of quality and efficacy for generic drugs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments